Silgan weighs bid for Gerresheimer – report

Group 1: Acquisition Consideration - US-based packaging company Silgan Holdings is considering a possible acquisition of German medical packaging manufacturer Gerresheimer, with a potential valuation of €41 ($47.22) per share [1] - Silgan is currently working with advisers on the proposal, but it remains uncertain whether a formal bid will be made or if any deal will be finalized [1] Group 2: Gerresheimer's Financial Challenges - Gerresheimer's market capitalization is currently €600 million ($694 million), with its share price having dropped more than 80% from its highs in 2023 and falling by 37% since the beginning of this year [2] - The company is facing significant challenges, including an expanded examination of its financial statements by Germany's financial regulator BaFin [2][3] Group 3: Silgan's Financial Performance - For the fourth quarter of 2025, Silgan reported net income of $18.2 million, down from $45.1 million in the same period of 2024 [3] - Silgan's full-year net income for 2025 rose to $288.4 million from $276.4 million in 2024 [3] - The company has projected adjusted net income per diluted share to range from $3.7 to $3.9 for 2026, a modest rise from its midpoint adjusted figure of $3.72 for 2025 [4] Group 4: Previous Acquisitions - In the previous year, Silgan completed its acquisition of Weener Plastics, a Dutch dispensing solutions provider, in a transaction valued at €838 million ($908 million) [4]